Activation-induced regulation of GABAA receptors: Is there a link with the molecular basis of benzodiazepine tolerance? - PubMed
Review
Activation-induced regulation of GABAA receptors: Is there a link with the molecular basis of benzodiazepine tolerance?
María Clara Gravielle. Pharmacol Res. 2016 Jul.
Abstract
Benzodiazepines have been used clinically for more than 50 years to treat disorders such as insomnia, anxiety, and epilepsy, as well as to aid muscle relaxation and anesthesia. The therapeutic index for benzodiazepines if very high and the toxicity is low. However, their usefulness is limited by the development of either or both tolerance to most of their pharmacological actions and dependence. Tolerance develops at different rates depending on the pharmacological action, suggesting the existence of distinct mechanisms for each behavioral parameter. Alternatively, multiple mechanisms could coexist depending on the subtype of GABAA receptor expressed and the brain region involved. Because most of the pharmacological actions of benzodiazepines are mediated through GABAA receptor binding, adaptive alterations in the number, structure, and/or functions of these receptors may play an important role in the development of tolerance. This review is focused on the regulation of GABAA receptors induced by long-term benzodiazepine exposure and its relationship with the development of tolerance. Understanding the mechanisms behind benzodiazepine tolerance is critical for designing drugs that could maintain their efficacy during long-term treatments.
Keywords: Benzodiazepine; Bretazenil (PubChem CID: 107926); Diazepam (PubChem CID: 3016); Flunitrazepam (PubChem CID: 3380); Flurazepam (PubChem CID: 3393); GABA; GABA(A) receptor; Gamma-aminobutyric acid (PubChem CID: 119); Imidazenil (PubChem CID: 119194); Tolerance; Uncoupling; Zolpidem (PubChem CID: 5732).
Copyright © 2015 Elsevier Ltd. All rights reserved.
Similar articles
-
Ferreri MC, Gutiérrez ML, Gravielle MC. Ferreri MC, et al. Neuroscience. 2015 Dec 3;310:152-62. doi: 10.1016/j.neuroscience.2015.09.038. Epub 2015 Sep 29. Neuroscience. 2015. PMID: 26391922
-
Foitzick MF, Medina NB, Iglesias García LC, Gravielle MC. Foitzick MF, et al. Neurosci Lett. 2020 Mar 16;721:134801. doi: 10.1016/j.neulet.2020.134801. Epub 2020 Jan 30. Neurosci Lett. 2020. PMID: 32007495
-
Assessing the efficacy of melatonin to curtail benzodiazepine/Z drug abuse.
Cardinali DP, Golombek DA, Rosenstein RE, Brusco LI, Vigo DE. Cardinali DP, et al. Pharmacol Res. 2016 Jul;109:12-23. doi: 10.1016/j.phrs.2015.08.016. Epub 2015 Oct 9. Pharmacol Res. 2016. PMID: 26438969 Review.
-
Schoch P, Moreau JL, Martin JR, Haefely WE. Schoch P, et al. Biochem Soc Symp. 1993;59:121-34. Biochem Soc Symp. 1993. PMID: 7910739 Review.
Cited by
-
Two Cases of Inadequate Response to Remimazolam.
Kitaura A, Hamasaki S, Sakamoto H, Tsukimoto S, Nakajima Y. Kitaura A, et al. Cureus. 2023 Jul 27;15(7):e42576. doi: 10.7759/cureus.42576. eCollection 2023 Jul. Cureus. 2023. PMID: 37637571 Free PMC article.
-
Zaric Kontic M, Dragic M, Martinovic J, Mihajlovic K, Brkic Z, Mitrovic N, Grkovic I. Zaric Kontic M, et al. Pharmaceuticals (Basel). 2023 Feb 21;16(3):331. doi: 10.3390/ph16030331. Pharmaceuticals (Basel). 2023. PMID: 36986431 Free PMC article.
-
Alberto Armas D, Hernández García V, Román Castillo Y, Santana Ayala JR, Capdevila Finestres F, Hardisson de la Torre A, Rubio Armendáriz C. Alberto Armas D, et al. Pharmacy (Basel). 2024 Jul 31;12(4):120. doi: 10.3390/pharmacy12040120. Pharmacy (Basel). 2024. PMID: 39195849 Free PMC article.
-
Regulation of GABAA Receptors Induced by the Activation of L-Type Voltage-Gated Calcium Channels.
Gravielle MC. Gravielle MC. Membranes (Basel). 2021 Jun 29;11(7):486. doi: 10.3390/membranes11070486. Membranes (Basel). 2021. PMID: 34209589 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources